Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

2008620 citationsJournal Articlebronze Open Access

Authors

Daniel J. Lovell · Cincinnati Children's Hospital Medical Center

Nicolino Ruperto · Istituti di Ricovero e Cura a Carattere Scientifico

Steven I. Goodman · Carolina Arthritis Associates

Andreas Reiff · Southern California University for Professional Studies

Lawrence Jung · Creighton University

Kateřina Jarošová · Institute of Rheumatology

Dana Němcová

Abstract

Adalimumab therapy seems to be an efficacious option for the treatment of children with juvenile rheumatoid arthritis. (ClinicalTrials.gov number, NCT00048542.)

Topics & Keywords

Autoimmune and Inflammatory Disorders Research Kawasaki Disease and Coronary Complications Adolescent and Pediatric Healthcare

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 359, Issue 8, pp. 810-820

DOI: 10.1056/nejmoa0706290

Field-Weighted Citation Impact: 21.88